Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MPC Injection in LVAD Recipients
NCT02362646Phase 2Completed
- Start
- Jul 2015
- Primary completion
- Aug 2018
- Modality
- Stem Cell Therapies
- Countries
- 2
01
Overview
A Phase 2 trial of rexlemestrocel-l in heart failure (HF). Started Jul 2015; status: completed.
02
Drugs
rexlemestrocel-l
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02362646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02362646.